Tevogen (TVGN) Other Accumulated Expenses (2022 - 2026)

Tevogen Bio Holdings (TVGN) has 5 years of Other Accumulated Expenses data on file, last reported at $98830.0 in Q1 2026.

• Quarterly Other Accumulated Expenses fell 78.68% year-over-year to $98830.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $98830.0 (down 78.68% YoY) and the FY2025 annual result came in at $331086.0, down 17.89% from the prior year.
• Other Accumulated Expenses fell to $98830.0 in Q1 2026, from $331086.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $463587.0 in Q1 2025 to a low of $61307.0 in Q3 2024.
• A 5-year average of $226872.4 and a median of $200000.0 in 2023 frame the typical range for Other Accumulated Expenses.
• The widest YoY moves for Other Accumulated Expenses: up 291.96% in 2025, down 80.7% in 2025.
• Tracing TVGN's Other Accumulated Expenses over 5 years: stood at $140000.0 in 2022, then fell by 14.18% to $120149.0 in 2023, then soared by 235.61% to $403233.0 in 2024, then declined by 17.89% to $331086.0 in 2025, then slumped by 70.15% to $98830.0 in 2026.
• The last three Other Accumulated Expenses figures came in at $98830.0 (Q1 2026), $331086.0 (Q4 2025), and $240296.0 (Q3 2025), per Business Quant data.